Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.87
-0.02 (-1.06%)
At close: Oct 16, 2025, 3:59 PM
1.96
4.81%
After-hours: Oct 16, 2025, 06:58 PM EDT
-1.06% (1D)
| Bid | 1.81 |
| Market Cap | 58.82M |
| Revenue (ttm) | 848K |
| Net Income (ttm) | -85.96M |
| EPS (ttm) | -2.24 |
| PE Ratio (ttm) | -0.83 |
| Forward PE | -0.81 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.01 |
| Volume | 554,238 |
| Avg. Volume (20D) | 1,331,109 |
| Open | 1.90 |
| Previous Close | 1.89 |
| Day's Range | 1.86 - 2.04 |
| 52-Week Range | 1.05 - 8.74 |
| Beta | 1.82 |
| Ex-Dividend Date | n/a |
About ACRV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-17.59%
ACRV stock has given up its prior gain. Acrivion T...
Unlock content with
Pro Subscription
5 months ago
-17.59%
Acrivion Therapeutics shares are trading higher after the company announced it will present data from its analysis of ACR-2316.
